Home > Press > Izon Science to sponsor Sydney 2010 International Nanomedicine Conference
Abstract:
New Zealand based nanotechnology company Izon Science, today announced its sponsorship and participation in the Sydney 2010 International Nanomedicine Conference. The three day nanomedicine conference, to be held 30 June to 2 July, will bring together researchers and developers from around the world working in targeted delivery, diagnostics and regenerative medicine.
"We're delighted to be a sponsor. Nanomedicine is an extremely exciting and important field. It has the potential to enable early detection and prevention, and to dramatically improve diagnosis, treatment and follow-up of diseases. By collaborating with researchers through forums like this we can continue to develop world leading technology that will help break new ground in healthcare", says Hans van der Voorn, the Executive Chairman of Izon.
Izon's qNano and qViro instruments combined with the newly launched Variable Pressure Module (VPM) provide the world's most comprehensive nanoparticle analysis system.
As part of the sponsorship package Izon is donating a major prize for a fundraising event at the conference to benefit the Children's Cancer Institute Australia. The prize package includes the use of a qNano for one year, with consumables, along with full training in New Zealand and support by Izon technical staff and the travel package to New Zealand.
Researchers using Izon's nanoparticle analysis system can measure and characterize virtually all particles including nanoparticles, viruses, bacteria and bioparticles such as exosomes and liposomes. Particle concentration, electrophoretic mobility, size and aggregation kinetics can all be analysed. Real time reaction monitoring allows users to design and test nanoparticle systems by analyzing the changes in particle properties as various modifications are applied. This is useful for bio-nano work, drug delivery research or development of diagnostic applications.
Izon's instruments are used across a wide range of scientific fields including nanomedicine, bionanotechnology, virology, vaccinology, microbiology, gene therapy, medical research, marine science, aquaculture, chemistry and nanoscience. Current projects include virus quantitation and analysis, oncolytic viruses, marine science, drug delivery systems, nanoparticle charge measurement, diagnostic applications using antibodies and nanoparticles, bioparticle analysis, and controlled dispensing of particles and biomolecules by count.
The Sydney 2010 International Nanomedicine Conference will be held at the Crowne Plaza Coogee Beach in Sydney. Izon Chairman Hans van der Voorn will deliver a brief presentation at the conference dinner on Friday 2 July.
####
About Izon Science
Izon provides the world's most comprehensive nanoparticle analysis system in a single instrument. Izon is a nanotechnology company focused on measurement, analysis and single particle control. Since commencement in early 2005, Izon has developed the science, hardware and software to fabricate and control dynamically resizable nanopores. These are a practical and cost effective means for the detection, characterisation and control of nanoparticles down to the molecular scale.
For more information, please click here
Contacts:
Hans van der Voorn
Executive Chairman, Izon Science
Phone: + 64 21 463 399
Sandra Lukey
Shine Group (Media for Izon Science)
Phone: + 64 21 2262 858
Copyright © Izon Science
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Events/Classes
A New Blue: Mysterious origin of the ribbontail ray’s electric blue spots revealed July 5th, 2024
Researchers demonstrate co-propagation of quantum and classical signals: Study shows that quantum encryption can be implemented in existing fiber networks January 20th, 2023
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||